Recently, a small-molecule inhibitor that interferes with the interaction between PTK7 and β-catenin exhibited anticancer effects in colorectal cancer by blocking the Wnt/β-catenin pathway [15]. This evidence concerns the gene PTK7 and colorectal cancer.